Loading...
XNAS
XFOR
Market cap45mUSD
Dec 05, Last price  
3.98USD
1D
4.74%
1Q
13.71%
IPO
-73.80%
Name

X4 Pharmaceuticals Inc

Chart & Performance

D1W1MN
XNAS:XFOR chart
P/E
P/S
17.76
EPS
Div Yield, %
Shrs. gr., 5y
77.13%
Rev. gr., 5y
%
Revenues
3m
0003,500,00003,000,0000002,557,000
Net income
-37m
L-62.98%
-13,218,000-22,975,000-33,877,000-43,021,000-56,604,000-62,131,000-88,696,000-93,867,000-101,167,000-37,450,000
CFO
-131m
L+35.63%
-10,816,000-21,639,000-27,871,000-40,903,000-48,055,000-58,818,000-70,905,000-77,102,000-96,512,000-130,901,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Actelis Networks, Inc., a networking solutions company, designs, develops, manufactures, and markets networking solutions for Internet of Things and telecommunication companies in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. It offers ethernet access devices, aggregation switches, broadband amplifiers, and repeaters, as well as element management systems software. The company also provides consulting, troubleshooting, remote support, training, product repairing, and software update services. It serves the intelligent traffic systems, education and industrial campus, airport, smart city, rail, military, energy, oil and gas, and water sectors. The company was founded in 1998 and is based in Fremont, California.
IPO date
Nov 16, 2017
Employees
40
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT